Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Jason G D, Gall"'
Autor:
Asif Shajahan, Cindy X. Cai, Jeremy Wolff, R. Sylvie Yang, Vera B. Ivleva, Daniel B. Gowetski, Jason G. D. Gall, Q. Paula Lei
Publikováno v:
Analytical Methods. 15:896-900
A strategy for the evaluation of different HAT (hemagglutinin variants) ratios on the FluMos-v1 mosaic nanoparticle influenza vaccine by LC-MS/MS-based PRM.
Autor:
Peifeng Chen, Anita Arthur, Kaitlyn M. Morabito, Kristin Leach, Xiaolin Wang, Grace L. Chen, Attila Nagy, Lauren A. Chang, Jon Cooper, Amy L. Chamberlain, Janel Holland-Linn, Olga Vasilenko, Alicia T. Widge, Shufeng Bai, Judith A Stein, LaSonji A. Holman, Cristina Carter, Iris Pittman, Deepika Gollapudi, Lisa A. Kueltzo, Colleen Fridley, Michelle C. Crank, Amritha Menon, William Whalen, Mridul Ghosh, Cynthia S. Hendel, Martha Nason, Amy Liu, Althaf Hussain, Laura Novik, Pernell Williams, Maria Burgos Florez, Robert T. Bailer, Thuy Nguyen, Brenda Larkin, Tracy J. Ruckwardt, Pamela Costner, Lam Le, Zhong Zhao, Elizabeth Carey, Vera Ivleva, Jennifer Walters, John R. Mascola, Jennifer Cunningham, Olga Trofymenko, Ya-chen Chang, Somia P. Hickman, Martin R. Gaudinski, Richard M. Schwartz, Slobodanka D. Manceva, Kevin Carlton, Barney S. Graham, Rahul Ragunathan, Jason G. D. Gall, Ana M. Ortega-Villa, Colin Tran, Sarah H. Plummer, Abidemi Ola, Ro Shauna S Rothwell, Ingelise J. Gordon, Mingzhong Chen, Jamie G. Saunders, Aba Mensima Eshun, Bob C. Lin, Azad Kumar, Nina M. Berkowitz, Xun Liu, Cora Trelles Cartagena, Emily Phung, Galina Yamshchikov, Joe Horwitz, Sarah O’Connell, Florence Kaltovich, Floreliz Mendoza, LaShawn Requilman, Man Chen, Preeti Apte, Christopher Lee, Renunda Hicks
Publikováno v:
Lancet Respir Med
Multiple active vaccination approaches have proven ineffective in reducing the substantial morbidity and mortality caused by respiratory syncytial virus (RSV) in infants and older adults (aged ≥65 years). A vaccine conferring a substantial and sust
Autor:
null Deepika Gollapudi, null Erwin Rosales‐Zavala, null Vera B. Ivleva, null Yanhong Yang, null Yile Li, null Sarah O'Connell, null Nicole A. Doria‐Rose, null Aakash Patel, null Daniel Blackstock, null Daniel B. Gowetski, null Kevin Carlton, null Jason G. D. Gall, null Q. Paula Lei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29ae8e189d46884d3d14430fca32dba0
https://doi.org/10.1002/btpr.3296/v2/response1
https://doi.org/10.1002/btpr.3296/v2/response1
Autor:
Deepika Gollapudi, Erwin Rosales‐Zavala, Vera B. Ivleva, Yanhong Yang, Yile Li, Sarah O'Connell, Nicole A. Doria‐Rose, Aakash Patel, Daniel Blackstock, Daniel B. Gowetski, Kevin Carlton, Jason G. D. Gall, Q. Paula Lei
Publikováno v:
Biotechnology progressREFERENCES. 38(6)
Broadly neutralizing antibody (bNAb) CAP256-VRC26.25 (abbreviated CAP256LS), a human IgGI monoclonal antibody targeting the V1V2 site of the HIV-1 envelope, has demonstrated high therapeutic potential as a broadly neutralizing monoclonal antibody aga
Autor:
Cheng Cheng, Lingshu Wang, Jason G D Gall, Martha Nason, Richard M Schwartz, M Juliana McElrath, Steven C DeRosa, John Hural, Lawrence Corey, Susan P Buchbinder, Gary J Nabel
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e33969 (2012)
The Step trial raised the possibility that uncircumcised men with pre-existing Ad5 neutralizing antibodies carried an increased risk of HIV infection after vaccination. Thus, understanding Ad seropositivity in humans is important to the development o
Externí odkaz:
https://doaj.org/article/bcf057da27b445979d32bde00c8cd4ac
Autor:
Cheng Cheng, LingShu Wang, Jason G. D. Gall, Martha Nason, Richard M. Schwartz, M. Juliana McElrath, Steven C. DeRosa, John Hural, Lawrence Corey, Susan P. Buchbinder, Gary J. Nabel
Publikováno v:
PLoS ONE, Vol 7, Iss 5 (2012)
Externí odkaz:
https://doaj.org/article/7c4c1402cece4c65bebe6bad0a4deed3
Autor:
Cheng Cheng, Jason G D Gall, Wing-pui Kong, Rebecca L Sheets, Phillip L Gomez, C Richter King, Gary J Nabel
Publikováno v:
PLoS Pathogens, Vol 3, Iss 2, p e25 (2007)
Recombinant adenoviral (rAd) vectors elicit potent cellular and humoral immune responses and show promise as vaccines for HIV-1, Ebola virus, tuberculosis, malaria, and other infections. These vectors are now widely used and have been generally well
Externí odkaz:
https://doaj.org/article/2c43de1347124144b7c865b52c63b6fd
Autor:
Robert T. Bailer, Maria Burgos Florez, Lucio Gama, Sung-Youl Ko, Zonghui Hu, Cynthia S. Hendel, Ro Shauna S Rothwell, Amarendra Pegu, Lily Zhang, Brenda Larkin, Katherine V. Houser, Jennifer Cunningham, Martin R. Gaudinski, Olga Vasilenko, Sandra Sitar, Julie E. Ledgerwood, Nicole A. Doria-Rose, Kathy Zephir, Preeti Apte, KC Cheng, William Whalen, Renunda Hicks, Richard A. Koup, Margarita M. Gomez Lorenzo, Floreliz Mendoza, Xiaolin Wang, Cristina Carter, LaSonji A. Holman, Young Do Kwon, Frank J. Arnold, Hope DeCederfelt, Grace L. Chen, Aryan M. Namboodiri, Peter D. Kwong, Kevin Carlton, Adrian B. McDermott, Joseph P. Casazza, Bob C. Lin, Nina M. Berkowitz, Nilusha Jayasinghe, Laura Novik, Catina R. Boyd, Edmund V. Capparelli, Carol Levinson, Galina Yamshchikov, Cora Trelles Cartagena, Carolyn M. Laurencot, Jason G. D. Gall, Michelle Conan-Cibotti, Sarah H. Plummer, Yunda Huang, Abidemi Ola, Pamela Costner, Ingelise J. Gordon, Janardan P. Pandey, Richard M. Schwartz, Judy Stein, Pernell Williams, Florence Kaltovich, Jamie G. Saunders, Iris Pittman, Milalynn Victorino, John R. Mascola, Barney S. Graham
Publikováno v:
The lancet. HIV. 6(10)
Summary Background Human monoclonal antibodies that potently and broadly neutralise HIV-1 are under development to prevent and treat HIV-1 infection. In this phase 1 clinical trial we aimed to determine the safety, tolerability, and pharmacokinetic p
Autor:
Clemente Diaz, Michelle Conan-Cibotti, Josephine H. Cox, Kimberly A. Dowd, Florence Kaltovich, John R. Mascola, Ingelise J. Gordon, Rebecca Lampley, Robert T. Bailer, Brittanie Brockett, Barney S. Graham, Doug Haney, Jeanine May, David Gordon, Kevin Carlton, Theodore C. Pierson, Nicolas Rosario, Yeycy Donastorg, Nina M. Berkowitz, Jason G. D. Gall, Richard A. Koup, André Cabié, Jason Mendy, Brenda Larkin, Sarah H. Plummer, Cristina Carter, Allison Beck, Jean W. Pape, Mark O’Callahan, Bruno Hoen, Charla A. Andrews, Amy Bray, Grace L. Chen, Julie E. Ledgerwood, Richard M. Schwartz, Emily E. Coates
Publikováno v:
JAMA. 323:1369
Importance Chikungunya virus (CHIKV) is a mosquito-borneAlphavirusprevalent worldwide. There are currently no licensed vaccines or therapies. Objective To evaluate the safety and tolerability of an investigational CHIKV virus–like particle (VLP) va
Autor:
Lisa A. Kueltzo, Vrc Study Team, Jonathan W. Cooper, Martin R. Gaudinski, Pamela Costner, Judith A Stein, Syed M. Moin, LaSonji A. Holman, Ingelise J. Gordon, Michelle C. Crank, Grace L. Chen, Lauren A. Chang, Azad Kumar, Nina M. Berkowitz, Juliane P. Hill, Jason S. McLellan, Kevin Carlton, Tracy J. Ruckwardt, Emily Phung, Anthony T. DiPiazza, Somia P. Hickman, Martha Nason, Julie E. Ledgerwood, Jason G. D. Gall, Peter D. Kwong, Galina Yamshchikov, John R. Mascola, Barney S. Graham, Man Chen, Richard M. Schwartz, Peifeng Chen, Kaitlyn M. Morabito
Publikováno v:
Science (New York, N.Y.). 365(6452)
Building a better RSV vaccine Respiratory syncytial virus (RSV) causes severe respiratory disease, especially in infants and the elderly. However, attempts to produce effective human vaccines have largely been unsuccessful. Structure-based design has